1. Circulating Cell-Free DNA as a Prognostic and Molecular Marker for Patients with Brain Tumors under Perillyl Alcohol-Based Therapy
    Giselle Faria et al, 2018, International Journal of Molecular Sciences CrossRef
  2. Ketogenic Diet in Cancer Prevention and Therapy: Molecular Targets and Therapeutic Opportunities
    Wamidh H. Talib et al, 2021, Current Issues in Molecular Biology CrossRef
  3. Ketogenic diet: a tool for the management of neuroendocrine neoplasms?
    Giovanna Muscogiuri et al, 2022, Critical Reviews in Food Science and Nutrition CrossRef
  4. Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development
    Thomas Chen et al, 2018, International Journal of Molecular Sciences CrossRef
  5. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials
    Franciele Aline Bruinsmann et al, 2019, Molecules CrossRef
  6. Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer
    Thomas N. Seyfried et al, 2020, Frontiers in Nutrition CrossRef
  7. Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up
    Ahmed M. A. Elsakka et al, 2018, Frontiers in Nutrition CrossRef
  8. Intranasal drug delivery: opportunities and toxicologic challenges during drug development
    Lea-Adriana Keller et al, 2022, Drug Delivery and Translational Research CrossRef
  9. Metabolic Drivers of Invasion in Glioblastoma
    Joseph H. Garcia et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  10. Ketogenic Diet for Cancer: Critical Assessment and Research Recommendations
    Jordin Lane et al, 2021, Nutrients CrossRef
  11. Ketogenic Nutrition and Health
    Ceren FİLİZ et al, 2022, Izmir Democracy University Health Sciences Journal CrossRef
  12. Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged
    Stefaan W. Van Gool et al, 2020, Cancers CrossRef
  13. Treatment of glioblastoma multiforme with “classic” 4:1 ketogenic diet total meal replacement
    Pavel Klein et al, 2020, Cancer & Metabolism CrossRef
  14. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial
    Martin Voss et al, 2022, European Journal of Nutrition CrossRef
  15. Effect of Ketogenic Diets on Cardio-Metabolic Outcomes in Cancer Patients: A Systematic Review and Meta-Analysis of Controlled Clinical Trials
    Alireza Amanollahi et al, 2023, Nutrition and Cancer CrossRef
  16. The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers
    Thomas C. Chen et al, 2021, Pharmaceutics CrossRef
  17. Feasibility and Safety of a Combined Metabolic Strategy in Glioblastoma Multiforme: A Prospective Case Series
    M. C. L. Phillips et al, 2022, Journal of Oncology CrossRef